Parisa Badiee

Parisa Badiee is a Research Fellow at Monash University's Drug Delivery Disposition & Dynamics department. Her work focuses on nanomedicine and drug delivery systems, particularly in cancer immunology and radiosensitisation strategies. She specializes in developing nanoformulations for therapeutic agents such as immunotherapeutics, kinase inhibitors, and miRNA, using platforms like high-density lipoprotein (HDL) nanoparticles and chitosan-based carriers.

Her research emphasizes enhancing drug efficacy through targeted delivery mechanisms to improve outcomes in oncology and ophthalmology. Key areas include optimizing nanoparticle stability, improving biodistribution of immunotherapies, and modulating tumor microenvironment responses. Notable projects involve radiosensitisation approaches combining chemotherapy and radiation therapy, as well as intratumoral delivery systems for PD-1 checkpoint inhibitors.

Her recent work (2022–2024) demonstrates a consistent focus on translational applications of nanotechnology in cancer treatment, including investigations into 3D tumor models and biomaterial design. No specific grants or advising roles are listed in the provided text, but her publications indicate active collaboration in interdisciplinary research teams.